Skip to main content

We have a selection of white papers we can provide you with to begin our discussions with your team. Please send us an email to request more information.

Kaycha Labs Bioavailability Study Results and Certificate of Analysis

ZHI now offering all global manufacturers interested in becoming a Licensee, its
proprietary technology for quantitative and proven Transdermal delivery of CBD.

TRANSDERMAL DRUG DELIVERY

by David Enscore

The greatest advantage of transdermal drug delivery over oral delivery is that the transdermally delivered drug enters the systemic circulation directly, bypassing the first pass through the liver and the metabolic degradation of orally administered drugs by the liver. Consequently, the bioavailability of transdermally administered drugs can be much greater than that for orally administered drugs.

Request Information

POSITION PAPER: TRANSDERMAL PATCH DELIVERY SYSTEMS FOR MEDICAL MARIJUANA—CLINICAL AND ETHICAL IMPLICATIONS

By Eric Knight MD, FRCP

From our current knowledge, it would appear that there is both an ethical and clinical need for development, research and practical use of transdermal (patch) delivery systems in the development of medical marijuana for the treatment of chronic conditions. Therapeutic transdermal patches are the most promising medical delivery system to avoid or minimize risk across a wide variety of clinical applications.

Request Information
Demonstration transdermal patch format with product tracking – delivers with convenience and discretion

Chewing gum has medical and practical advantages as a delivery method for medical marijuana.
Chewing gums are not ‘gummies’ and have a long history of successful use in controlled delivery formulations of many substances.

By Eric Knight MD, FRCP

Eight reasons to consider chewable gum as a vehicle for controlled delivery of bioactives.

Request Information
Demonstration gum format – multiple gums in convenient blister package